Danish company making progress in Merck-deal
Nordic Bioscience is currently carrying out extensive phase II trials that the Danish company has to conduct for Merck Serono in accordance with a partnership deal.
by Stefan Singh Kailay
Recruitment of patients is well underway and verything is running according to plan for Nordic Bioscience in what is a pivotal collaboration agreement for the Danish company.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish biotech to go it alone
For abonnenter
The times they are a-changing
For abonnenter
